Center/Research Area Affiliations
Dr. Veldman is interested in studying corneal transplant procedures, including Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet’s Membrane Endothelial Keratoplasty (DMEK). Of particular note, he published a review on the evolving role of DSAEK after DMEK became the procedure of choice in endothelial keratoplasty. His research during fellowship focused on the introduction of a stromal-sided S-stamp in DMEK, which has markedly decreased the incidence of upside down DMEK graft implantation—a primary cause of graft failure. Dr. Veldman is also studying corneal endothelial rehabilitation in the absence of corneal transplantation, specifically in Fuchs Endothelial Dystrophy, and is the acting Principal Investigator following a cohort of these patients.
For a full publication list, please see his CV.
Veldman PB, Terry M, Straiko M. Evolving indications for Descemet's stripping automated endothelial keratoplasty. Curr Opin Ophthalmol. 2014 May 30.
Terry MA, Straiko MD, Veldman PB, Talajic JC, VanZyl C, Sales CS, Mayko ZM. Standardized DMEK Technique: Reducing Complications Using Prestripped Tissue, Novel Glass Injector, and Sulfur Hexafluoride (SF6) Gas. Cornea. 2015 Aug; 34(8):845-52.
Veldman PB, Dye PK, Holiman JD, Mayko ZM, Sáles CS, Straiko MD, Stoeger CG, Terry MA. Stamping an S on DMEK Donor Tissue to Prevent Upside-Down Grafts: Laboratory Validation and Detailed Preparation Technique Description. Cornea. 2015 Sep;34(9):1175-8.
Veldman PB, Dye PK, Holiman JD, Mayko ZM, Sáles CS, Straiko MD, Galloway JD, Terry MA. The S-stamp in Descemet Membrane Endothelial Keratoplasty Safely Eliminates Upside-down Graft Implantation. Ophthalmology. 2016 Jan; 123(1):161-4.
Borkar DS, Veldman PB, Colby KA. Treatment of Fuchs Endothelial Dystrophy by Descemet Stripping without Endothelial Keratoplasty. Cornea. 2016 Jun 15. (Epub ahead of print)
View a list of publications on pubmed.gov>>